Medicare Part D – Page 13 – medicarereport.org

A trusted source for Medicare news and education from the AMAC Foundation.

Health Care Finance Part D/Prescription Drugs

Pharmaceutical costs expected to rise 3.35% in 2026: Vizient

(By: Alexandra Murphy for Becker’s Hospital Review ) Pharmaceutical prices are expected to rise by 3.35% in 2026, according to

Eileen Cook July 31, 2025July 31, 2025 Healthcare Costs, Healthcare Finance, Medicare Part D

Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Medicare Advantage in 2025: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization

(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul

Eileen Cook July 30, 2025July 30, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Out-of-pocket costs, Premiums, Prior Authorization, Supplemental Benefits

Health Care Finance Legislative Update

Tariffs expected to raise imported drug costs: 4 notes

(By: Alexandra Murphy for Becker’s Hospital Review ) A trade deal between the U.S. and the European Union will impose

Eileen Cook July 30, 2025July 30, 2025 Healthcare Costs, Healthcare Finance, Imported Drugs, Medicare Part D, Tariffs

CMS Health Care Finance Part D/Prescription Drugs

2026 Medicare Part D Bid Information

The Centers for Medicare & Medicaid Services (CMS) has released preliminary technical Medicare Part D bid information for the 2026

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, Medicare Part D

CMS Health Care Finance Medicaid Medicare - General Medicare Advantage Part D/Prescription Drugs

Medicare Advantage in 2025: Enrollment Update and Key Trends

(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, MedPAC, Older Adults

Health Care Finance Health Care Redesign Legislative Update Part D/Prescription Drugs

How health systems are preparing for a potential 340B overhaul

(By: Alexandra Murphy for Becker’s Hospital Review ) As federal scrutiny and legislative proposals continue around the 340B drug pricing

Eileen Cook July 29, 2025July 29, 2025 340B drug discount program, Healthcare Costs, Healthcare Finance, Healthcare redesign, Medicare Part D

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters

(By Juliette Cubanski and Tricia Neuman for KFF Health News Published: Jul 16, 2025) Ahead of Medicare’s annual mid-year announcement

Eileen Cook July 17, 2025July 17, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Key Facts About Medicare Part D Enrollment, Premiums, and Cost Sharing in 2025

(By Juliette Cubanski and Anthony Damico for The Kaiser Family Foundation Published: Jul 16, 2025) The Medicare Part D program

Eileen Cook July 17, 2025July 17, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

What is the Medicare prescription cap

Two types of Medicare plans cover your prescription drug needs: Stand-alone Medicare Part D plans or Medicare Advantage prescription drug

Eileen Cook July 10, 2025July 10, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Medicare Prescription Cap, Older Adults

Health Care Finance Legislative Update Part D/Prescription Drugs PBM’s

The Trump administration’s approach to PBMs, so far: 5 things to know

(By: Rylee Wilson for Becker’s Hospital Review ) President Donald Trump has signed two executive orders aimed at reducing the

Eileen Cook June 24, 2025June 24, 2025 Healthcare Costs, Healthcare Finance, Medicare Part D, PBM Industry